# Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults

> **NCT07706361** · NA · NOT_YET_RECRUITING · sponsor: **LifeWave, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- GHK and GHK-Cu Blood Levels

## Interventions

- **DEVICE:** X39 Patch
- **DEVICE:** Placebo Patch

## Key facts

- **NCT ID:** NCT07706361
- **Lead sponsor:** LifeWave, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706361, "Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*